Taika Capital, LP Medpace Holdings, Inc. Transaction History

Taika Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$187.26 - $240.17 $1.03 Million - $1.33 Million	-5,526 Reduced 22.3%	19,249 $4.62 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $1.49 Million - $2.05 Million	8,575 Added 52.93%	24,775 $4.66 Million
Q4 2022 Feb 09, 2023	BUY	$153.06 - $226.57 $1.76 Million - $2.61 Million	11,520 Added 246.15%	16,200 $3.44 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $626,961 - $788,356	4,320 Added 92.31%	9,000 $1.42 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $679,208 - $854,053	4,680 New	4,680 $736,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Taika Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Taika Capital, LP with notifications on news.